Siqiang Zheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Siqiang Zheng has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Bin Zhao
Shandong public health clinical center
1 shared publication- Bo Tao
Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China
1 shared publication - Enkuo Zheng
Second Hospital of Ningbo
1 shared publication Jinpeng Wang
Department of Orthopedics, Center for Orthopedic Science and Translational Medicine, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai, China
1 shared publicationLei Xie
Second Affiliated Hospital of NanChang University
1 shared publication- Liang Guo
Shanghai Pulmonary Hospital
1 shared publication
Latest Publications
- 17 April 2026
- Published by Springer Nature in Advanced Fiber Materials
- Vol. 8 (6) , 2290-2310
Immunoprotective Multifunctional Nanofiber–Hydrogel Janus Membranes for Advanced Ectopic Cartilage Regeneration
- 17 April 2026
- Published by Springer Nature in Advanced Fiber Materials
- Vol. 8 (6) , 2290-2310
Immunoprotective Multifunctional Nanofiber–Hydrogel Janus Membranes for Advanced Ectopic Cartilage Regeneration
- Open Access
- 19 December 2024
- Published by Springer Nature in Research Square
Differential Diagnosis of Pulmonary Arterial Hypertension via Deep Multimodal Modeling of Noninvasive Measurements
Background Pulmonary hypertension (PH) is a rare yet progressive disorder characterized by elevated blood pressure in the arteries of the lungs, often presenting without an evident cause. The distinction between pulmonary arterial hypertension (PAH) and PH due to left heart disease (PH-LHD) is crucial due to differences in treatment approach and prognosis. A correct diagnosis is essential to ensuring that patients receive the appropriate treatment. However, the current diagnosis of PAH and PH-LHD faces clinical limitations due to its reliance on invasive hemodynamic measurements or the limits of data modeling. Methods We conducted a retrospective study involving 905 PH patients from Shanghai Pulmonary Hospital, incorporating CT images and clinical textual data. A heterogeneous graph neural network was constructed on multimodal data. We developed and validated a heterogeneous network to predict the probability of PAH and PH-LHD. The new method exhibits strong discrimination between PAH and PH-LHD. Findings In the multiple cross-validations, it achieved a 0.943 AUC when using a combination of image and textual data, a 0.869 AUC for only textual variables, and a 0.715 AUC for only images. It also evaluated the type-dependent performances, yielding the best AUC (0.896) when using a subgroup of variables. The best performance (AUC=0.809) can be achieved by using only ECG variables in our model. Interpretation Our study provides a quantitative rationale for modulating multimodal data to enhance differential diagnosis of PAH and PH-LHD with only noninvasive measurements.
- 19 December 2024
- Published by Springer Nature in Research Square
Open AccessDifferential Diagnosis of Pulmonary Arterial Hypertension via Deep Multimodal Modeling of Noninvasive Measurements
Background Pulmonary hypertension (PH) is a rare yet progressive disorder characterized by elevated blood pressure in the arteries of the lungs, often presenting without an evident cause. The distinction between pulmonary arterial hypertension (PAH) and PH due to left heart disease (PH-LHD) is crucial due to differences in treatment approach and prognosis. A correct diagnosis is essential to ensuring that patients receive the appropriate treatment. However, the current diagnosis of PAH and PH-LHD faces clinical limitations due to its reliance on invasive hemodynamic measurements or the limits of data modeling. Methods We conducted a retrospective study involving 905 PH patients from Shanghai Pulmonary Hospital, incorporating CT images and clinical textual data. A heterogeneous graph neural network was constructed on multimodal data. We developed and validated a heterogeneous network to predict the probability of PAH and PH-LHD. The new method exhibits strong discrimination between PAH and PH-LHD. Findings In the multiple cross-validations, it achieved a 0.943 AUC when using a combination of image and textual data, a 0.869 AUC for only textual variables, and a 0.715 AUC for only images. It also evaluated the type-dependent performances, yielding the best AUC (0.896) when using a subgroup of variables. The best performance (AUC=0.809) can be achieved by using only ECG variables in our model. Interpretation Our study provides a quantitative rationale for modulating multimodal data to enhance differential diagnosis of PAH and PH-LHD with only noninvasive measurements.